Strategies for preventing respiratory syncytial virus
- 1 December 2008
- journal article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 65 (23_Supplem), S13-S19
- https://doi.org/10.2146/ajhp080440
Abstract
Purpose. Prevention of respiratory syncytial virus (RSV) infection—crucial for decreasing the burden associated with this disease—is discussed.Keywords
This publication has 30 references indexed in Scilit:
- Ten years’ experience with year-round active surveillance of up to 19 respiratory pathogens in childrenEuropean Journal of Pediatrics, 2007
- Evaluation of Compliance With Palivizumab Recommendations in a Multicenter Study of Young Children Presenting to the Emergency Department With BronchiolitisPediatric Emergency Care, 2007
- Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory TractJournal of Molecular Biology, 2007
- Respiratory Syncytial Virus ProphylaxisNeoReviews, 2005
- Rate of palivizumab administration in accordance with current recommendations among hospitalized childrenJournal of Pediatric Health Care, 2004
- Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart diseaseThe Journal of Pediatrics, 2003
- Factors Predicting Compliance with Palivizumab in High-Risk InfantsAmerican Journal of Perinatology, 2001
- Nosocomial Respiratory Syncytial Virus Infections: The "Cold War" Has Not EndedClinical Infectious Diseases, 2000
- Handwashing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus.Archives of Disease in Childhood, 1991
- Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmissionThe Journal of Pediatrics, 1990